105324641
commented on
1
105324641
liked
$Esperion Therapeutics (ESPR.US)$
Bullish Case for Esperion (ESPR): $7 to $10 by Jan 2027
Esperion Therapeutics (ESPR) is positioning itself for a massive growth trajectory as it heads into 2026 and beyond. With a transformative combination of regulatory catalysts, global partnerships, and a robust pipeline, the company is poised for a **sharp revaluation** in the coming 12–18 months.
A key game-changer for ESPR will be the **updated European...
Bullish Case for Esperion (ESPR): $7 to $10 by Jan 2027
Esperion Therapeutics (ESPR) is positioning itself for a massive growth trajectory as it heads into 2026 and beyond. With a transformative combination of regulatory catalysts, global partnerships, and a robust pipeline, the company is poised for a **sharp revaluation** in the coming 12–18 months.
A key game-changer for ESPR will be the **updated European...
1
3
105324641
liked
$Esperion Therapeutics (ESPR.US)$ Buying more dips! The price now is even lower than the share diluted price they had recently for shares public offering.
The ESPR stock has good fundamentals due to a moat that has a patent for their bempedoic acid cholesterol medication for the next few years. Plus this medication is recently approved as a first line medication in Europe for cholesterol treatment. Japan and other countries will be prescribing more of this medication in the next few months with...
The ESPR stock has good fundamentals due to a moat that has a patent for their bempedoic acid cholesterol medication for the next few years. Plus this medication is recently approved as a first line medication in Europe for cholesterol treatment. Japan and other countries will be prescribing more of this medication in the next few months with...
1
105324641
liked and commented on
$Esperion Therapeutics (ESPR.US)$Esperion Therapeutics GAAP EPS of -$0.16 misses by $0.08, revenue of $87.3M beats by $9.5M (ESPR:NASDAQ)
EPS miss, but revenue beats estimates. and company says should be profitable by Q1 2026
EPS miss, but revenue beats estimates. and company says should be profitable by Q1 2026
2
4
105324641
commented on
$Esperion Therapeutics (ESPR.US)$ esperion earnings report 6th Nov premarket.
how do you think it will go?
how do you think it will go?
4
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
105324641
commented on
$SharpLink Gaming (SBET.US)$
Tokenization market to reach $2 trillion by 2028, Ethereum to dominate: Standard Chartered
11/01/2025 08:56:38 GMT
|
By
Michael Ebiekutan
Standard Chartered's Geoffrey Kendrick estimates the RWA market could reach $2 trillion by 2028.
The analyst stated that the stablecoin boom is driving disruption in traditional finance.
The bank expects much of the on-chain activity within the projected period to occur on Ethereum.
Tokenization market to reach $2 trillion by 2028, Ethereum to dominate: Standard Chartered
11/01/2025 08:56:38 GMT
|
By
Michael Ebiekutan
Standard Chartered's Geoffrey Kendrick estimates the RWA market could reach $2 trillion by 2028.
The analyst stated that the stablecoin boom is driving disruption in traditional finance.
The bank expects much of the on-chain activity within the projected period to occur on Ethereum.
1
105324641
liked
$Pacific Biosciences of California (PACB.US)$ you stay down until i load more cheaper
1
105324641
liked
$Pacific Biosciences of California (PACB.US)$ to the moon and beyond
2
105324641
liked
$Bitfarms (BITF.US)$ IREN got new deal maybe this will go up a bit
2
2
![[empty]](https://static.moomoo.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://static.moomoo.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)
![[loading]](data:image/svg+xml;base64,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)
105324641 : It is estimated that the situation will be dire, as both figures are below forecasts.